School of Pharmacy - News

MSc (Pharm) Jonna Tenhunen investigated the regulation of sirtuins in her doctoral thesis. Sirtuins are possible targets for drugs in many diseases such as cancer, neurological diseases, and metabolic disorders.

Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala.

The doctoral thesis of Jonna Weisell, MSc, provides novel information about the mechanisms underlying calcific aortic valve disease CAVD.

Several UEF researchers representing the fields of medicine and molecular medicine were ranked in world's top 10,000 scientists for career-long impact. Ranked in the top 100 in their own field were particularly researchers representing forest sciences.

Knee osteoarthritis was associated with clinically significantly lower health-related quality of life (HRQoL) scores, but pain experience and depressive symptoms had a greater effect on HRQoL than radiographic findings alone.

New models may be beneficial in the testing of novel drugs to treat schizophrenia.

Fetal period is the most sensitive time of life to the effects of chemicals and thus exposure of pregnant women is most harmful.

The serum metabolite profile can be used to identify individuals likely at risk of developing an alcohol-related disease in the future.

Funded projects study the role of glial cells in Parkinson’s disease and develop a new drug against resistant bacterial infections.